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p < 0.03) or dtpyltdaawk (3.00 * 0.83 mumto per 6 p < 
0.01,. 
Tk dogs were m&r&d into three treatmml f?ews: 
control (r&S). dipyridsmole (n=lO) or WEB.2086 
,o=lth an sntaamdst of tbe effects of tw emtoptaaas 
Considerable experimental evidence 11-7) implicates the 
acute inflammatory process and activation ofneutrophils in 
the pathogen& of reperfusion-indwed myowdial injury. 
Tbe detrimental e5ects of neatrophils appear to be mediated 
at least in part by their unfavorable effects on regional 
myocardial perfusion. After is;iznia followed by rep&u- 
Sian. these leukocytes contribute orbe no reflow phenom- 
enon by randomly plugging capillaries and increasing edema 
fomtation (8.9). Recently, it was also shown 001 that acti- 
vated neuttopbils act as effecters of reduced coronluy flow 
and myocxdial fanction even in the presence of normal 
coronary perfusion pressure. This finding suggested tbal 
alterations in the micracirculation might play a more impor- 
tant role than previously thought in the patbophysiology of 
isckmic heart disease, such as during unstable angina 
pecloris or in the development dfoeal areas of necrosis and 
fibrosis commonly seen in patients with coronary artery 
disease (II). 
The aim of this study, Iherefore, was to determine if 
aiierations in regional mywudiat perfusion and va.scular 
resistance could be evidenced in a model of irchemic chal- 
lenge different from *he model cf corn&e curoua; b oxlu- 
sion used in most studies and to determmc if !!!ex alter- 
ations could be modified by pharmxoiogr agents known rn 
affect gmnulocytcs and plalelet activation. Fur that purpose. 
twu agents were rttndomly admmistered to the study a”,- 
mals. The first was dipyridamole. whxh by increasing m- 
gional conccmations of adenosinc (12) k a potent men- 
&dilator and may indirectly inhibit plalelet aggregatron and 
neutrophil activation (5.9). The second agent was a platelet- 
activating factor antagonist becwsc it has been supgested iL1 
the1 the damage caused to the mrcrocirculalion might be 
partially related to the local release of this mediator. Platelet- 
activating factor is a phospholipid rclcancd by animal and 
human cells in inflammation and allergy. causing plalrlrt dnd 
neuttwhil wrwtion (13.11L The triazolodiazeom dcriv- 
alive WEB-%86% a highly specific compe:itive aitagonisl of 
platelet+.ctivating factor. Because this agent is nontoxic and 
has nodirect hemodynanuc effec~s(lS.lh), it i5 an interesting 
tool to analyze some of the derrimcntal consequences of 
ischemia and reperfusion. 
Methods 
Ex@ttwrttal preparalion. Thirty-five mougrel dog: 12~ 
to 30 kg) underwent thoracotomy under sterii? conditions 
during sodium pentobarbital anesthesia (2tJ mglkg body 
weight). A Tygon catheter was implanted in the left atrial 
appendage for injection al radiolabeled microspherer. A 
micromanometer (JSI CdOO, lanssen Scientific Instruments) 
was inserted into the IeR venlricle through a stab incision at 
the apex. Electrodes for right atrial pacing and monitoring of 
the electrocardiogram (ECG) were sutured to the right attial 
appendage and the ventricular walls. The left anterior de- 
scending carunary artery was dissected free near its origin 
and fitted with acuff ofcluder. Pairs of piezoelectric rystals 
were then implanted into the ventricular walls at the suben- 
docardial level and oriented to provide the greatest nmpli- 
tude of segmental shorlening in this area (Scummicrometer. 
Triton Technology). One pair was placed in the area per- 
fused by the left anterior descending artery downstream 
fmm the occluder and a control pair was inserted into the 
territory perfused by the left circumflex artery (17). The 
catheters and wires were subcutaneously tunneled to lhe 
neck and the dogs were allowed 8 lo IO days to recover. All 
dogs had normal temperature and appetite as well as normal 
blood gases at the time of the siudy. The expen’mental 
pmtocol had been approved by the Commission for Animal 
Research of the Belgian “Fends de la Recherchs Scienri- 
fiquc Mddicale.” 
Sludy pmloml (Fig. 1). The dogs were sedated with 
morphine (IO mg intramuscularly) and prnpionylpromazine 
(5 mg intramuscularly) !o conform to the guiding principles 
of the American Physiological Society. They were brought 
to the laboratory and a 5F Polyvinyl catheter wds inlroduccd 
,phcrcs: Dip = dipyridam&: TTC = tiiphenyltetnzolium chloride: 
well = WEB-!(186. 
under local anesthesia mto the right femorat artery to record 
arterial blood pressure and calibrate microsphere blood Row 
measurements by the artificial argan method (18). The dogs 
were allowed to rest quietly on a table ?ld atropine (0.5 mg 
intravenously) was admmistered lo prevent atnoventricular 
dissociation during high rate atrial pacing. Once hean rate 
had stabthzed after atmpine injeclion, a sef of control 
hemodynatrnc vanab~es was recorded, including injection 
into the left atrium of radiolabeled microspheres (I to 2 
million. diameter I6 t 0.5 pm. labeled with gadolinium-153. 
tin.1 13. strontium-85, niobium-95. and cobalt-57, New En- 
gland Nuclear). Immediately before and for 2 min after 
injection, a reference anerial blood sample (IO mUmin) was 
drawn to calibrate regional blood Rows (IS). 
A@ rowrol dorm recurding. the c.uR occluder was 
slowly inflated using a screw-driven syringe under continu- 
OUP monitoring of the segment.length loop. I&lion was 
continued until stable severe hypokinesia without dyrkinesia 
of the ischemic zone (systolic shortening osb to 6%) was 
reached. A complete set of data, including regional blood 
Row, was obtained once dysfunction was considered stable. 
At this stage. a control test of atrial pacing at high rate (is0 
10 210 beatsimin) was able to provoke dyskinesia in the 
ischemic segment. The preparation remained in this %w 
Raw ischemic” state for M) min afIer stenosis. This period 
was followed by another 60 min of repeated episodes of high 
demand ischemia superimposed on the low flow state @trial 
pacing at high rate for 1 min every 5 min). At the end of this 
2 h period, regional function and blood flow as well as global 
IeA ventricular function variables were again recorded. 
true infiision. Saline solution fn= I3 does), ditwrida- . 
mole (n=IO) or WEB-2C86 (n=l2) was lbeb infu&i for 
IO min before the occluder was deflated. Dipyridamoie was 
administered intravenouslv as a slow bolos iniection (IO rng) 
followed by a continous i4 h infusion at n I& of I8 rr@?$ 
per day (Gnseby-MS 26 Portable Mini-Pumps) using a 
solution of diovridamole at 50 m,xlml brousht to PH 3 with 
citrate. WEB-2086 dissolved in s&e solution was adminis- 
tered intravenously as a bolus injection of 2 mglkg followed 
by an infusion at a rate of 24 mgikg per day. 
Aqerjusion. A complete set ofdata was obtained IO min 
after reperfusion. The dogs were brought back to their 
kennels with the infusion pump connected to the left atrial 
catheter. Twentv-four hours after rewfusion. the final set of 
hemodynamic &d regional Row data was obtained in the 
same experimental conditions as the day before and without 
stopping the drug infusion (Fig. I). Finally, the dogs were 
anesthetized by pentobubital (20 m&) before the heart 
was arrested by injection of potassium chloride. The heart 
was removed immediately for further analysis. Blood sam- 
ples for plasma dipyridamok or WEB-2086 levels were 
drawn IO min and 24 h after reperfttrion. 
Data analysis. Hemodynamic data were recorded on an- 
alog magnetic tape (Honeywell 101) and on paper (Gould ES 
IOOO). The IS1 04Kl micromanometer had a linear gain up to 
3W mm H% and a Aat frequency response UP to 15 kHz; its 
zero level was adjusted to match the aortic pressure during 
systole recorded by means of the fluid-filled catheter con- 
nected to a Statham P23dB transducer. Analog data were 
digitized every 2 ms and processed on-line by means of a 
Hewlett-Packard A900 computer, as described previously 
(17,191. As indexes of inotropic state, we used the peak 
positive value of the first derivative of left ventricular 
Pressure (dP/dt) and the value of dP/df at a developed 
pressure of 40 mm Hg and normalized for this developed 
pressure (DP)_that is, (dP/dt)DP, (20). The time constant 
T, of the exponential left ventricular pressure decrease 
during the first 40 ms after peak negative dP/dt was used as 
en index of left ventricular relaxation rate (21). For regional 
wall motion analysis. end-diastolic (ED) and end-systolic 
(ES) segment lengths (SL) were determined at the peak of 
the R wave on the ECG and at the time of peak negative 
dP/dt, respectively. Percent systolic shortening was calcu- 
lated as: IO0 x (EDSL-ESSLYEDSL. 
Determination of the area at risk, myocardial necrmis and 
regional blaed Bow. With the atria and right ventricular free 
wall removed, the left anterior descending coronary artery 
WBE tied at the level of the occluder and Evans Blue dye was 
inj .*ed into the circumflex artery and proximal left anterior 
descending artery to color the normally perfused area. The 
heart was then cut into five or six slices, I to I.5 cm thick, 
perpendicular to the long axis. The apex with the site of 
micromanometer implantation was excluded from analysis. 
Thereafter, the basal surfaces of the heart slices and margins 
of the area et risk were traced onto acetate sheets. The slices 
were placed in a solution of triphenyltetrazolium chloride at 
37°C for 30 min. After triphenyltetrazolium chloride staining, 
endocardial (inner halO and epicardial (outer halo sampling 
for regional myocardial blood Row was made in the center of 
the necrotic area if any (unstained area). in ischemic hat 
noninfarcted tissue (stained area) and in nonischemic muscle 
(22:. lschemic samples were cat to avoid contamination by 
nonischemic and necrotic tissae. The size of myocardial 
infarct and area at risk were measured by planimetry. 
Myocardial b,ood,low was calculared by rhe e,juuorion: 
Qm = Km x R)ICr. where Qm = myocsrdial bled flow 
(ml/rein). Cm = tissue counts (countslmin), R = reference 
arterial blood Row and Cr = counts in reference blood 
sample. Samples were counted in a scintillation well counter 
at aoumoriate enerw windows (Canberra. S 85 Model) 122). 
Foikacd dog, fiow~were aver&d for the contml area; the 
area at risk without necrosis and the area with confluent 
necrosis. Coronary vascular resistance was estimated as 
mean aortic pressure/coronary flow. 
Stattical analysis. Data presented are mean values + 
SD. Statistically significant ditierences between and within 
groups were assessed using a two-way analysis of variance 
for all the hemodynamic variables. When significance was 
detected, paired or unpaired t tests were p rformed when 
appropriate, using the Bonferonni correction (23) adapted to 
the degree of freedom in the analysis of variance. In this 
analysis of variance, the mean values of Row or resistance 
for each dog within each region were used as individual data 
points, even though a diffennt number of samples was 
obtained in each dog. For the comparisons of the ischemic 
threshold, in which only one data set was available for 
be&veer. group comparisons and in which date were not 
nonoally distributed, a Mann Whitney U test was used. 
ReSUltS 
Global and R.-gional Left Ventricular Function 
Tables t to 3 summarize the main retevanr variables 
during the time course of the protocol in the three groups of 
dogs. Myocardial necrosis wes not noted at the level of the 
crystals recording wall motion in the ischemic zone in any 
dog. However, 24 h after reperfusion, intraventricular con- 
duction defects had appeared in one control dog and in two 
dogs in the dipyridamole group. Because of wall motion 
asynchrony, regional function was not compared with pre- 
reprfusion values in these animals. 
Cwtrol group (Table 1). Stenosis of the left anterior 
descending coronary artery resulted in significant increases 
in end-diastolic and end-systolic lengths of the ischemic 
segments and significant decreases in percent shortening. 
There were no significant changes in percent shortening of 
the normal segments. Heart rate. left ventricular systolic 
pressure and end-systolic pressure increased (74 + I5 mnm 
Hg during control to 76 i IS and 80 * 20 mm Hg after hcote 
and 2 h stenosis. respectively: p = NS) and mean aortic 
pressare remained stable. The changes in isovolumetrie 
indexes of inotropic state or relaxation were also insignili- 
cant. 
Ten minutes afki rcpqfuusion, indexes of regional func- 
Iion in the ischemic segment were slightly improved com- 
pared with prerepelfusion values. but none of these changes 
reached statistical signiiicare. Furthermore, regional sys- 
tolic function subsequently tended 11) deteriorate in most 
dogs and 24 h later percent shortening had returned to 
prereperfusion values (5.6% wsus 5.4%) despite a slight 
decrease in systolic pressure. The end-diastolic length ofrhe 
ischemic segment also remained increased above the control 
value after 24 h of repwfusion. These changes were zccom- 
panied after 24 h of reperfusion by a significant depression in 
Jobal indexes ofcontractility below control valuer (- 17% in 
peak +dPldt; -18% in [dP/dtlDP,; both p < 0.01). 
Camoariwn of dioMidarode and coohd ~WUBE ITable 2). 
As in th’e control g&p, there were no cons~ste~l changes in 
heart rate. left venlricular systolic pressure or global indexes 
of left ventricular function during the 2 h of coionary 
stenosis before dipyridamole infusion. Percent shortening of 
!he ischemic segment was well matched in the two groups 
before coronary stenosis (17.8% and 18% in the control and 
dipyridamok groups, respectively). Regional function imme- 
diately after coronary cuff inflation was also comparable in 
the two groups, with significant increases in enddiastolic 
and end-systolic segment length and decreases in percent 
shonening to 4.1 + 5.3% in the dipyridamole group versus 
4.4 t 6.3% in rhe control group. During the 2 h of ischemia. 
regional left ventricular function in the dipyridamole group 
continued to deteriorate slightly to a percent shortening of 
2%. These changes occurred in the absence of any drug 
injection or any adjustment in occkder i&lion and were 
not statistically significant when compared with values in the 
comml group. 
During dipyridamole infusion (averape plasma concentra- 
lion atIer LO min 0.64 &ml, range 0.16 LO 1.26; after 24 h. 
1.81 &oL range 1.24 to 3.06) there was a moderate but 
signi&?@ decrease in left ventricular systolic pressure, 
end-systolic pressure (from 85 I! 16 to 71 + 16 mm Hg: p < 
0.01) and mean aortic pressure. Ten minutes and 24 h atIer 
repelfusion, both end-diastolic and end-systolic segment 
lengths and percent shortening of the ischemic segment were 
significzotly improved over values before dipyridaomte infu- 
rion and repafusion. Moreover, after 24 h. the end.diastolic 
kngth of the ischemic segment had returned to control 
wlues. In absolute values, however. systolic shorteniw of 
toe ischemie segment was not signi&tly better th& in 
control dogs (oercent shozenine IO.8 + 9.6% in the diov- 
ridamole group versus 5.6 L 7.3% in the control group; i= 
PIS). 
WEB-M group and mmparkoo with control group (To. 
bk3). Asinthetwoothergroups, heartrate,kftventricutar 
systolic pressure and global indexes of left ventricular func. 
Iion remained stable during the 2 h of coronary stenosis 
before WEB-2086 administration and reperfusion. The 
changes in regional function after slmosis also paralleled 
those noted in the control and dipyridaowk groups. The 
administration of WEB-2086 before rawfusion had no effect 
on left ventricular pressure. mean aoriic pressure or indexes 
of global and regional left ventriculu function. Ten minutes 
after repetision during WEB-2C@6 it&ion (average plasma 
coocsnlmtion 1.44 &mt, range 0.83 u) 3.68) the end- 
diastolic and end-systolic segment length of the iscbemic 
segment were sigoificaotly improved over prereprfwion 
values. During the next 24 h, there was a prognssive 
reduction in kft ventricualr svstolic messwe. and repional 
systolic function continued to imp&e sligbtl; in the &I- 
fused area. However, the regional systolic function 24 h after 
reperfusion (average pk.& concentration I.81 &rot) was 
not better io the presence of WEB-Z@6 than io control 
conditions (5.5 f 6.4% versus 56 t 7.3%. p = NS). 
Furthermore, in contest IO the data after dipyridamole. 
end-diastolic length of the ischemic segment did not return to 
baseline values 24 h after reperfusion with WEB-2086, 
Myocardial Perfusion. Regional Coronary 
Vascular Resistance and Myocardial Necrosis 
Tables 4 to 6 summarize the changes in mean aortic 
pressure. regional blood flow and coronary vawlar resis- 
tance in the three groups of dogs. 
Anrsatrkkrrltboutevidemeeof-(Tabla4106). 
In all three groups, endocardial sod epicardial blood llow 
were comparable before stenosis in the areas at risk and in 
the control weas. Regional perfusion decreased sigoificaotly 
during coronary stenosis and Le values measured after 2 h 
were not sigoiticantly dilferent from those obtained immedi- 
ately after creation of the stenosis. In the control gmup 
(Table 4) 10 min after reperfusion. endow&al flow was 
lower in the area at risk than in the control area in 1G of I2 
dogs (p < 0.1). Twenty-four hours after repcrfwiun. this 
trend had become siemficant: endwardial Row was arnifi- 
candy lower in the area at risk than in the control arca 
(-14%; p < 0.M) and the coneoponding area at baseline 
study (-21%; p < 0.05) and the coronay vascular resistance 
was signiticanlly higher. No significant difference in epcnr- 
dial Row was noted between reperfused and control arca in 
ffow and coronary vascular &istance were comparxhle in 
control and reperfused areas after IO min and after 24 h. 
However, epicardial flow remained lower in the reperfused 
areas than in the control epicardium at both periods. All flow 
valuer obtlined during dipyridamok administrauon were 
Gwficantly greater than values oblained at baseline (p < 
0.011 and I” cantrz! dogs. 
Lr rl:r ilrwp fwred wirh WEB-2086 (Table 6). endocar- 
dial Row during slenosis was reduced more than in the 
con!rol or dipyridamok-treated groups. Despite lhij more 
were ischema no doTerence in endocardial or epicardial 
flow dnd reskmnce was noted between the contml area 
nnd arex dl nsk afrer 10 min and 24 h of rcperfusion. 
Thu\. when abrolute blwd Row and coronary va,i&r 
resistance were compared after 24 h of repelfusion. il 
amxsred ihat endocardial blood Row in reoerfused areas 
&s rigmfcandy bIgher than m fonlrol doga both in dogs 
Created wrth diwridamole (3.00 2 0.83 versus I.@4 I 
0.15 mlimin pe;;, p c 0.01) and in d?gs treated wirh 
WEB-2086 (I.44 2 0.?8 versw I .(u * 0.15 mllmin perg. p < 
0.031. Smilarly. coronary vascular resistance *as lower in 
the tvfo treated groups than in the control dogs: -65% with 
dipyridamole (p < 0.01) and -36% with WEB-2086 (p < 
0.03). 
Necrotic oreas (Tnbles 4 to 61. Confluent mvxxdial 
necrosis was detected by triphenyltetrazolium.chlorjde 
staining in 9 of 13 control dops, 5 of 10 dogs treated with 
dipyridamole and 7 of 12 dogs &ted with WEB-2086. In all 
three groups. endoeardial Row in the area of confluent 
necrosis tended to be lower at baseline study. After reper- 
fusion, calculated coronary vascular resistance remained 
higher than in the control areas in these segments with 
em-fluent necrosis, even in dipyridamole-treated o@. As a 
result of very low residual Row in some of these necrotic 
areas, hiih values of calculated resistawe were frequently 
obtained even after reperfusion, thereby explaining the 
larger standard deviation of this variable in necrotic areas. 
In percent of fhe men 01 risk, the amount of necmsis 
(conlh~rd plus patchy) was not d&rent among groups: 41? 
18% in the control group, 35 -C 17% in the dipyridamole 
groop and 46 + 20% in the WEB-2086 group. However, 
because the amount of necrosis depends not only on the 
duration of ischemia and on the reperfusion damage but also 
on the severity of ischemia, the threshold of flow reduction 
necessary to induce confluent necrosis ivas compared in the 
three groups (Fig. 21. In control dogs, the average value of 
minimal endocardial flow found in the area at risk with no 
necrusis or with negligible signs of patchy necrosis (area of 
patchy necrosis <I50 mm’, that is, =z5 % of the area of risk) 
was 58% of the endocardial Row in the normal zone. This 
threshold was signilicantly greater than in the dogs treated 
with d&dam& (27%. p < 0.025) or WEB-2086 (25%. p < 
0.01). Thus, a greater eduction in endocardial Row had been 
necessary in both ireated groups to produce confluent myo. 
cardial necrosis. 
Discussion 
Model of low Row, high demand isehemis. The purpose of 
this study was to verify the hypothesis that regional myo- 
cardial perfusion could he impaired alla an ischemic insult 
less severe than total coronary occlusion. In thii perspec- 
tive. three aspects of our results are worth disettssittg. The 
first are the changes in regional blood ilow observed afIer 
repafosion in our model of low flow, high demand ischemia. 
To enhance the clinical relevance of these changes. a con- 
scious sedated dog model was used. Indeed, there are 
frequently opposite results in open chest anesthetized and 
Figure 1. l~dividal values of minimal endocardial (Endo) blood 
Row observed in the area at risk without evidence of necrosis (or 
with negligible signs of patchy necrosis) in each treatment group. 
Dipyridamole (DIPY) or WEB-2086lWEB) treatment allowed areas 
with more severe ischemia than in control areas to be free of 
necrosis. Data are expressed as a percent of the endwardial Row of 
Ihe normally perfused area and each data point correswnds to one 
of the dogs in which at least one slice fmm lhe area BI risk WBS free 
orco”R”e”l necr‘xis. 
conscious dog preparations, particularly in r&moo to infarct 
sin reduction after drug therapy wt. rbe lack of beneli, 
being seen r~~t often in conscious dogs Tbic doTerence cm, 
be explained by the longer follow-up permd in conscious 
animals, altJwing all mechanisms. including inflammatorv 
reaction. to fully play their detrtmental role. Moreover. wi 
chose a model of low Aow. on which we superimpowd 
episodes cf high demand whemra rather than complete 
coronary occlusion. The hlgb demand epwdes of iscnemin 
me close to fbe clinical situation in which coronary artery 
narrowing does not occur under perfectly stable nemody- 
namic conditions, but is rccompanied by stre‘err and reflex 
mechanisms that increase oxygen requirements. 
Alterations in sobendwardial p~fusion after rep&&n. 
In this model. sianificant alterations MI endoealdial flow and 
coronary vascular resistance and postischemx dysiunrtion 
in nonnecrotic areas (“myocardial stcnnmg”) (?S! were oo- 
wved in cmtttol dogs 24 h atler repetiusion. As usual. come 
degree of heterogeneity and variability in redonal blood 9ow 
was noted among dogs despite a comparabk reduction in 
seemental shortening dotins ‘he episode of coronary stenosis. 
Nevertheless. the average residual endowdial blood How 1x1 
the “stunned arezx” wasoo the orderof0.72 t 0.14 ml/mm pfr 
g(that is, a modetale hypoperfusion only). In these areas. the 
index of endwtrdidial coronary vascular resistance was in- 
creased by 269 24 h aiter roperfusion compared wilh rhe 
control &a. I‘his sogests that-moderote flow reduction may 
be sticient to trigger functional alterations in the suhendocar- 
dial micmvascutature. 
Potential mk of eden&. Our data indicate that these 
alterations in the subendocardinl microvasculature are at 
least partially reversible with pharmacologic interventions. 
Indeed, dipyridamole. which increases regional adenosinr 
concentration by inhibiting adenosine deaminase and aden- 
osine uptake by the red cells, was able to sigoiticantly 
increase regional perfusion in the ischemic area to a level 
close to the flow in the control area. Increased regional 
adenosine concentration by another agent, 4.amino+ 
imidazole catboxami.ie, has also been shown (9) :o have 
benelsia! effects on regional flow, gtanulocyte accumulation 
and injury tier coronary occlusion and reperfusion. Iowa- 
coronary infusion of adenosine has also been shown (26.27) 
to reduce microvascular injury induced after pmlonged 
&hernia and reprfusion. Several mechanisms may underly 
the beneficial effects of increased regiooal adenorine in our 
experimental conditions and in the various models of total 
coronaty occlusion. It has bee,1 proposed (5.9) that in 
addition to its vasodilator action, adenosice could act as an 
anti-injury autacoid that IiPks catabolism of. high energy 
phosphate stores to inhibition of granulocyte adherence. 
mierovosoular obstruction (capillary plugging) and superon- 
ide anion formation. Adenosine also modifies the o~rovas- 
cular permeabili!y to macromolecules (28). which may re- 
duce rce~onal edema formation nod tbercbv imorovc 
perfuwm by another indirect mccbani<m. 
Platelet-activstina factor. Among the various factors that 
may acwate granulocytes dorms whemia. one could be 
pt:,telct-;lctl\.attng factor (5). In ow studtes, the administm- 
Tim of WEE-1086. a highly specific pla:elel-activating factor 
anr.igon!rt. \eleusely pwented the mcrca% in coronary 
v~xulw rc+~ance in the wooed area wirhout a&tine car+ 
wry r~~stance in the normal zone. Because Row rcduwion ib 
the arcs at n\k tended to be more severe in this treate~d group 
than m the control group. the lack of change in coronary 
vaxuiilr reri%ance is unlikely to be related to less severe 
ischcmla bcforedlucadminisiration. Tbisconfimts the hypoth- 
es!? ihat It: plaIeiet-activaliog factor was invol<cd ii the 
cascade of nents leading to the regional iocrzw in vo.wdar 
re%limw. However, the fact that no rolctivc hyperemia could 
k demomtrdted in the stunned area IO min after rcpetfusion 
with WEB~Xk6. while it was still possible to increase flow in 
this area wth dipyridamole. mdicates that vasonwtor compo- 
nents and other ~riggeen of ydnulocyte and platelet activation 
play d role in regional alteraoons in resislance after rep&u- 
%on. Our data thereicrc indicate that platelet-activating factor 
is not the sole mediator involved. 
DdRrences in left ventricular diastolic pressure among 
aroops are unlikely to be responsible for the observed 
differences in wbendocardial prfus~on because left venttic. 
ular end-diasto!? pressure alle; reperiix~on was comparable 
in the three groups. Similarly, regional function appeared 
comparable, so that differences in perfusion related to dif- 
ferences m oxygen demand can probably be ruled out. 
However. because the value of the mean aortic preswre was 
used to calculate the index of iesistancr. the index also 
incorporated all possible modifications occurring in epicar- 
dtal ve~srl~ and in larger transmorsl anerioles. Funher 
studies are needed to precisely locate the damage to the 
coronary vascular bed responsible for the observed hyp 
perfusion in control dog. Finally, neither WEB-2086 nor 
rtipyridamole could nonna!ize resistance and perfusion in 
occrotic areas. This finding is in agreement with pwious 
studies 129) showing that the degree of no reflow co! alated 
rvtrh the extent of infarction. 
Tl,c &rrs of dipyridamok nnd WEE-2fB5 suppon the 
hy,ourhe~h that in moderate low flow. high demaod iscbemia, 
ganukxytes and plateiets are activated by a series of factors 
that lead to altuatioos in myocaniiil periwioo. These dak 
together wxh other exptimental studies (30) suggest that the 
pstbophysiologic role of nelitrophil and platelet activation may 
extend beyond the field of thmmbolysis and should be exam- 
ined in patients with severe angina pectoris. From a clinical 
viewpoint. oordataatso irriicate that the phenomenon may to 
some exwd be prevented by pharmacologic interveniion. 
Regionional mywwtii hlnetEti~1 after rep&~&n. The infu- 
sion of WEB-2086. although it improved perfusion. had no 
significant effect on the recovery of the stunned area after 24 
h. It appears unlikely that ,his lack of benefit was related Lo 
dose. Indeed. the dose adminislered has been shown to be 
futtv et%cetive in other modcts of DIa,cIc,-Pc,iva,inp iac,or 
&&ion (15.16). It is more probable that the lack ofe6ect 
of WEB-2086 on the rate of recovery reflects in addition to 
the release of plateletativating factor and platelel acliva- 
tion the influence of many other factors Such as free oxygen- 
derived radicals and calcium overload in the llathowesis of _ 
the stunned myocardium (1). 
In this model, dipyridamolr wcamtenr srorrrd (II IIIC rime 
of reperfwian tended to improve the recovery of the isch- 
emit segment after 24 h and there was a quick recovery of 
the end-diastolic length ofthe segment. which did not occur in 
control or il? WEB-ZM&ated dogs. Impaired diastolic func- 
iion with creep and sarcome~ elongation is a major anomaly in 
the Stunned myocardium (31) ara functional recovery generally 
parallels recovery of nomad diastohc dimensions. The most 
obvious mechanism to explain the slightly greater functional 
benefit in the dipytidamole group is the decrease in systoiic 
pressure caused by the Systemic vasodilation. An afterterload 
reduction alone or together &it, a reflex increase in sympa- 
thetic drive mi&t, indeed. ac.comt for the improvement in 
systolicshorteningintheslunned ;rea(TableZ).Theenhanced 
shoftening coxomjtantly ahswed in the normal zone was 
highly suggestive that this mechanism was operating in our 
study animals. However, we cannot rule out !hat other prop 
e&s of dipyridamole could be involved in this effect. Dipy 
ridamok, by its pawful dilating effecls on small arterioles. 
increawd regional blood Row well above the values noted alter 
administration of WEB-U)86 and it is known that an increased 
pafusion early a&r iscbemia may be su&ien, to improve 
function (32). 
Redudion io irreversibte myocmdiat damage. In our ex- 
perimeotal model, the threshold of blood flow a, whit: 
confluent extensive necrosis was observed was relatively 
high in control dogs. Indeed, in this group, extensive necro- 
sis was frequently iourid in areas where endocardial residual 
Row during stenosis ranged between 40% and 60% of the 
control zone. Tnis lhreshold was significantly lower in 
treated dogs. Because the dwgs we given only at the time 
of rewfusion, this difference indicates that moderately 
ischemic cells, which would have died after normal rep&. 
lion, had been orotected bv diavridamole or WEB-2086. . 
Canclusi~ns.‘Our data &e in agreement wilh previous 
repmts (l-7) showing the detrimental role of the inflamma- 
tory reaction and of the no reflow phenomenon in rep&u- 
sion injury. They also indicate that this parhophysiologic 
mechanism, in which regional production of platelet- 
activating factor seems involved, is active well before the 
extreme situation of total occlusion occurs and may play a 
rote in most forms of severe coronary ancry disease; it! 
effects may be limited by thempcuiic interventions tha, 
influence granulocyte and platelet aclivation. 

